Clinical Pharmacokinetic Interactions between Herbal Supplements and Anticancer Drugs

Keyphrases

• Docetaxel 100%
• Anticancer Drugs 100%
• Pharmacokinetic Interaction 100%
• Clinical Pharmacology 100%
• Herbal Supplements 100%
• Herbal Anticancer 100%
• Cancer Patients 85%
• In Cancer 71%
• Pharmacokinetics 71%
• St. John's Wort 57%
• Cytochrome P450 2D6 (CYP2D6) 57%
• Grape Seed Extract 57%
• Cytochrome P450 Enzymes 42%
• Tolbutamide 42%
• Dextromethorphan 42%
• Cytochrome P450 3A4 (CYP3A4) 28%
• Milk Thistle 28%
• Echinacea Purpurea 28%
• Recommended Dose 28%
• Herb-drug Combination 28%
• Herb-drug Interaction 28%
• Cancer Treatment 14%
• Chemotherapy 14%
• Plasma Concentration 14%
• CYP2C9 14%
• Plasma Parameters 14%
• Quality Control Analysis 14%
• Biotransformation 14%
• Systemic Exposure 14%
• Alkylamides 14%
• Inter-patient Variability 14%
• Healthy Volunteers 14%
• Clinical Effect 14%
• Undertreatment 14%
• Undertreated 14%
• Commercial Products 14%
• Inhibiting Effect 14%
• Metabolic Ratio 14%
• Liquid Extract 14%
• Response to Chemotherapy 14%
• Essential Enzymes 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Pharmacokinetics 100%
• Pharmacokinetics 100%
• Anticancer Drug 100%
• Malignant Neoplasm 87%
• Docetaxel 87%
• Clinical Study 62%
• Hypericum perforatum 50%
• CYP2D6 50%
• Grape Seed Extract 50%
• Cytochrome P450 37%
• Tolbutamide 37%
• Dextromethorphan 37%
• Chemotherapy 25%
• Tamoxifen 25%
• CYP3A4 25%
• Silybum Marianum 25%
• Drug Interaction 25%
• Combination Drug 25%
• Echinacea purpurea 25%
• Normal Human 12%
• CYP2C9 12%
• Carboxamide 12%